Boxer Capital, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Boxer Capital, LLC

  • $1.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $20.4 Million - $31.2 Million
100,000 New
100,000 $23.1 Million
Q3 2018

Nov 14, 2018
SELL
$207.3 - $300.31 $19.7 Million - $28.5 Million
-95,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$101.55 - $313.9 $9.65 Million - $29.8 Million
95,000 New
95,000 $26.6 Million

Others Institutions Holding MDGL

# of Institutions
295
Shares Held
21.9M
Call Options Held
819K
Put Options Held
644K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.58B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email